{"name":"NanoBio Corporation","slug":"nanobio-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"NB-001 (0.3%)","genericName":"NB-001 (0.3%)","slug":"nb-001-0-3","indication":"Other","status":"phase_3"},{"name":"Vehicle versus NB-001","genericName":"Vehicle versus NB-001","slug":"vehicle-versus-nb-001","indication":"Influenza","status":"phase_3"}]}],"pipeline":[{"name":"NB-001 (0.3%)","genericName":"NB-001 (0.3%)","slug":"nb-001-0-3","phase":"phase_3","mechanism":"NB-001 is a nanoemulsion formulation designed to deliver antimicrobial or antiviral agents topically with enhanced penetration and bioavailability.","indications":[],"catalyst":""},{"name":"Vehicle versus NB-001","genericName":"Vehicle versus NB-001","slug":"vehicle-versus-nb-001","phase":"phase_3","mechanism":"NB-001 is a vaccine.","indications":["Influenza"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNbU8xWVdianc1djVkd2dWMTRPempBZ3FCMVU5SDN0T05yS0ZNWHhPbmxiMUtYMVpEZ2F2X2IyZ2Z5Y004Q1VmQmVrTjJzUzZkM1oxTlVwREJHelMyaExPNmk0ZHkzS1lrc2l0eXdkdDZPNDAxNkxPUV9tRHdvQi1nR1Z3dS1yQQ?oc=5","date":"2023-03-17","type":"pipeline","source":"Dermatology Times","summary":"Leon Kircik, MD, FAAD: The Evolving Acne Arsenal - Dermatology Times","headline":"Leon Kircik, MD, FAAD: The Evolving Acne Arsenal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOQUxRbHJldmhKRk84R0doTHg2VnZIVFRCa2owZ1dHSFdhWldhRHNBWllHTTVJNVVEOHZTNVFSdXJuaGhBMHg0N3BxeDd5OXRuTldGYk5ITkRJd01tMDIxR0pCVEpXQVNUejJQTVEzMS1xeWZCdWN1MWprYlA4bm9va1p5dXBGSjhvbWlhLW1LcTR1Vnl5QVZ1SDhKSjdFc1B1c2lpMzNvUzZnSjAtMkZyQWJ3?oc=5","date":"2018-05-06","type":"pipeline","source":"Crain's Detroit Business","summary":"NanoBio raises $10 million funding round, changes name - Crain's Detroit Business","headline":"NanoBio raises $10 million funding round, changes name - Crain's Detroit Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNd3BKOW9LaGZuUzF6NGZPNmotYmw2czRtZjJYeHJQVDZIanAwdVJjWFJNY3JfeENibFA3ZW1LMHBEM0ZkLWU0aW5Idmp1Q1F3YUhSQlk2WGpSRVBSTXhxUmRpYXZvdF9oWWNON0ZIRktheE1udTE4amhUZE1XSm9hQ2JMd1VNNHF0eEVwQkZrc0R2eGFDM0M5NHB6OW9LeVhIYlE?oc=5","date":"2007-07-11","type":"pipeline","source":"Crain's Detroit Business","summary":"NanoBio gets $2.4M grant from state fund - Crain's Detroit Business","headline":"NanoBio gets $2.4M grant from state fund - Crain's Detroit Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNUEJCMXo5b1ptR2FadGxWUk13VGxlQ2tMaWdxRExMcnJrcEhEb1o4ekVWNlN4dGtQSlpKZUlyVG1lZ2RmMks1bEt6YlpZeEdXUm9YOFpDdEVLNExzY2drVEtoV1Vva2Nnak5BWlVVY1pRdFk5SUZDY1R0TnJJcllxSkVseGtTQQ?oc=5","date":"2004-12-07","type":"pipeline","source":"Crain's Detroit Business","summary":"NanoBio names CEO - Crain's Detroit Business","headline":"NanoBio names CEO - Crain's Detroit Business","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}